Introduction
Introduction

Airway inflammation, such as asthma, chronic obstructive pulmonary disease and infection, is a frequent condition whose incidence has increased. Therapeutic strategies currently in use often rely on the use of anti-inflammatory agents such as glucocorticoids (GC). GC have been shown to enhance innate immune responses, including those related to the toll-like receptors (TLRs)
. While the suppressive effects on inflammatory signalling are well characterized and are shown to involve protein-protein interactions between glucocorticoid receptor (GR) and transcription factors such as NF-B and AP-1 [2] , the pro-inflammatory effects of GC still remain mechanistically unresolved.
TLRs have been shown to be crucial in triggering epithelial innate immune response by recognizing pathogen-associated molecular patterns (PAMPs) and stimulating host immune cells against several microbial products [3] . To [6, [9] [10] [11] [12] . Lung epithelial cells actively secrete and respond to inflammatory cytokines [1, 13] that are produced when the TLR2 signalling pathway is activated [6] . Once TLR2 is activated by gram-positive bacteria, MyD88 and TIRAP adaptor proteins are recruited to the receptor intracellular domain [14] . The serine/threonine kinase, IRAK, is subsequently recruited leading to an interaction of the TLR complex with the downstream signalling molecule TRAF6 which subsequently activates NF-B [14] , Jun amino terminal kinase [3] , extra cellular signal related kinase and p38 MAP kinases [15] . The phosphatidylinositol 3-kinase (PI3K) and small GTPase Rac1 can also participate in the TLR2 signalling pathway activated by Staphylococcus aureus [9] . Rac1 controls NF-B-dependent gene expression and transactivation through the alternative PI3K signalling pathway after TLR2 [9] or TLR4 activation [16] .
GC have been reported to increase tumour necrosis factor (TNF)␣ and Haemophilus influenza induced expression of TLR2 mRNA and protein. This action seems to be mediated by up-regulation of MAPK phosphatase 1 and negative cross-talk with p38
MAPK [1, 17] . Moreover, TLR2 and TLR4 mRNAs were shown to be induced in resting but not activated white cells [18, 19] [25] . 
Material and methods
Reagents and antibodies
A synthetic bacterial lipopeptide Palmitoyl-Cys((RS)-2,3-(dipalmitoyloxy)-propyl)-OH (
Immunoblots and immunoprecipitation
Results
Mutual inhibition of PI3K and GR activity in cells pulsed with Pam 3 -Cys-Ser-Lys 4
GC have been shown to enhance innate immune response in clinical studies and animal models [26, 27] . Recently (Fig. 1 D) either in the presence or absence of dexamethasone (Fig. 2C) , suggesting that PI3K also positively regulates AP-1-mediated transcriptional upon TLR2 activation. [30, 31] .
Physical interaction between PI3K and GR
The TLR2 intracellular domain as well as the GR steroid binding domain contain tyrosine residues vulnerable to phosphorylation when activated by microbial products or steroid agonists, respectively. This molecular event may promote PI3K subunit p85 recruitment to phospho-tyrosine residues. To evaluate the role of GR on TLR2 signalling activation, co-immunoprecipitation assays were conducted on cells overexpressing TLR2-Flag, p85 and GR recombinant vectors. The diagram in Fig. 3A shows the location of potential p85 subunit recruitment consensus motifs (YxxM) in the amino acid sequences of TLR2 and GR. (These results obtained using the DS Gene v1.5 Accelrys software, Inc., San Diego, CA, USA) The TLR2 intracellular domain and the GR steroid-binding domain, both located at the carboxyl-terminus of their molecules, contain one and two YxxM motifs, respectively. This observation is supported by the evidence that the p85 subunit co-immunoprecipitates with GR and this interaction is enhanced by dexamethasone in vivo [29]. Cells treated with dexamethasone induced a 2-fold increase in the GR/PI3K immunoprecipitated product as compared to untreated cells (Fig. 3B, lanes 1 and 3). Treatment with dexamethasone in the presence of 1 g/ml Pam3-Cys-Ser-Lys4 did not change dexamethasone-induced GR/p85 co-immunoprecipitation (Fig. 3B, lanes 2 and 4). These data suggest that activated GR is needed to enhance GR/PI3K interaction. In addition, treatment with dexamethasone did not alter TLR2/p85 coimmunoprecipitation (Fig. 3C) suggesting that PI3K recruitment to the TLR2 intracellular domain is not modulated by GC. Moreover, TLR2 agonist did not alter TLR2/p85 co-immunoprecipitation. Experiments were also conducted to assess the impact of PI3K on GR-mediated transcriptional activation in cells transiently coexpressing the MMTV-Luc and p85-DN constructs. When the PI3K dominant negative was expressed (p85-DN), a significant inhibition of GC-induced transcription was observed (Fig. 3D) indicating that p85 recruitment to GR is important for GR-mediated gene transcription. These finding indicate that there is a cross-talk between GR and PI3K that results in mutual inhibitory function.
Functional analysis of GR, and YxxM-GR mutants
We next evaluated the molecular mechanism underlying the interaction between PI3K and GR. Experiments were conducted to assess the impact of PI3K as well the GR tyrosine mutation on GR-mediated transcriptional activation in cells transiently coexpressing the MMTV-Luc and p85-DN constructs or YxxM-hGR mutants (Y598F-hGR, Y663F-hGR or Y598/663F-hGR), respectively. When both tyrosine residues in the YxxM-GR motif are mutated, a slight reduction in GC-mediated transcription was seen indicating that phosphorylation of these amino acids has some role in receptor-mediated gene transcription (Fig. 4A). Experiments were then completed to show if the interaction between GR and PI3K is functionally involved in regulating TLR2-induced TNF-␣ expression. COS-1 cells transiently expressing the Y/F-hGR mutant recombinant vectors were treated with dexamethasone in the presence or absence of 10 g/ml Pam3-Cys-SerLys4 and intracellular TNF-␣ expression was determined by flow cytometry. Pam3-Cys-Ser-Lys4 induced a rise in TNF-␣ expression that is synergized by co-treatment with dexamethasone in cells transiently transfected with empty vector (control) or wt-GR (Fig. 4B). TLR2 activation in cells expressing the Y/F hGR mutants also showed an increase in intracellular TNF-␣; however, dexamethasone co-treatment repressed the Pam3-Cys-Ser-Lys4
effect on cytokine expression (Fig. 4B). Dexamethasone treatment alone increased intracellular TNF-␣ in cells expressing the Y/F GR mutants suggesting that GR is a platform for TLR2 signalling pathway regulation which may require intact phosphorylation sites
These data indicate that a PI3K dominant negative effect is enhanced in cells where the YxxM p85 recruitment motifs in GR are altered and in the presence of TLR2 and GR agonists. Interaction between p85 and GR was studied in COS-1 cells expressing the wt-GR and YxxM-hGR mutant recombinant vectors: Y599F-hGR, Y663F-hGR or Y598/663F-hGR, together with p85. Upon dexamethasone treatment p85/GR interaction was exclusively detected in cells expressing the wt-GR construct but not with any of the YxxM-hGR mutants (Fig. 4C). These data indicate that activated GR is needed to enhance GR/p85 interaction and that both tyrosine residues, present in the steroid-binding region of GR, are required for p85 recruitment to GR.
Discussion
In 
control). (C) GR and p85 co-immunoprecipitation assay in COS1cells. COS-1 cells overexpressing p85-wt and hGR mutant constructs were exposed to 100 nM dexamethasone for 12 min. and immunoprecipitated with antibody raised against GR was, then solved in a SDS-PAGE and blotted with an anti-p85 antibody (the Western blots shown are representative of three independent experiments).
has similar pro-inflammatory effects in other settings of epithelial activation remains to be determined. PI3K phosphorylates 3-phospholipids that in turn activate a series of cellular intermediates including tyrosine kinases, small G proteins and serine/threonine kinases such as protein kinase C (PKC-) and Akt [32] .
Recent studies have found that, in neutrophils and HEK293 cells, PI3K has a positive rather than a negative regulatory role on pro-inflammatory cytokine production [33] [40, 41] . The molecular mechanism by which PI3K activates NF-B does not appear to be involved in the nuclear translocation of NF-B but does increase the duration and magnitude of the phosphorylation state [42] [43] [44] (Fig. S2A and B) 
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Fig. S2 GR translocates into the nucleus of transfected cells in response to dexamethasone. (A) The subcellular distribution of wt-GR, Y598F-GR, Y663F-GR and Y598/663F-GR mutants was measured in the absence and presence of a range of dexamethasone doses (0-100 nM). A representative image for each condition is shown. COS-1 cells were transiently transfected with plasmids expressing wt-GR, Y598F-GR, Y663F-GR or Y598/663F-GR
